Targeting IL-6 reduces IgM levels and tumor growth in Waldenstrom macroglobulinemia
W. Han, S. J. Matissek, D. A. Jackson, B. Sklavanitis, S. F. Elsawa
This study shows that Tocilizumab reduces tumor growth and IgM secretion in a mouse model of Waldenstrom macroglobulinemia by targeting IL-6.
bioRxiv · Apr 2, 2019Cancer Biology